AF
AMLX icon

Allworth Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History

Allworth Financial’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467 Sell
26
-14
-35% -$217 ﹤0.01% 4860
2026
Q1 		$556 Buy
40
+28
+233% +$394 ﹤0.01% 4712
2025
Q4 		$145 Hold
12
– – ﹤0.01% 4742
2025
Q3 		$164 Buy
+12
New +$113 ﹤0.01% 4624
2023
Q4 		– Sell
-100
Closed -$1.83K – 3460
2023
Q3 		$1.83K Buy
+100
New +$2.12K ﹤0.01% 2584

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Allworth Financial's AMLX Position: Q2 2026 in Review

Allworth Financial reduced its Amylyx Pharmaceuticals (AMLX) stake by 35% in Q2 2026, selling an estimated $217 and leaving 26 shares worth $467. The position accounts for ﹤0.01% of the portfolio, ranked #4860.

Allworth Financial first reported a position in AMLX in Q3 2023 and has held it in 5 quarters since. The position peaked at $1.83K in Q3 2023. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Allworth Financial held 26 shares of Amylyx Pharmaceuticals worth $467 as of Q2 2026.
  • Allworth Financial sold 14 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $217.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4860 holding.
  • Allworth Financial first reported a position in Amylyx Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • Allworth Financial's Amylyx Pharmaceuticals position peaked at $1.83K in Q3 2023.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.